Stanley Wunderlich
Chairman & CEO
swunderlich@cfsg1.com
The founding partner of CFSG1, Mr. Wunderlich brings to his clients nearly 40 years of experience in Wall Street activities. A specialist in corporate development and the formation of triangular reverse mergers, he has participated in numerous initial public offerings, private placements of equities and institutional private equity offerings. Mr. Wunderlich helped launch two previous investment banking firms, the Renaissance Group and Krieger, Wunderlich, Fialkov, Scheinman & Company. He has also served as Managing Director of J.T. Moran & Co., as a Registered Principal at Dunhill Equities, and as Managing Director at Robert Todd Financial. He is noted for the close relationships he has forged with key brokers/dealers, venture capitalists, institutional investors, research analysts, media personnel and other global private equity source.
Listed in Who’s Who in Executive Management, Mr. Wunderlich is a former member of LIFT (Long Island Forum for Technology) and a former member of the American Stock Exchange Arbitration Panel. He holds a B.A., L.L.B. and most major credits toward his M.B.A. in Executive Management. A proud former member of the United States Marine Corps, he is a two-time “Ironman” World Championship finisher.

Daniel Stepanek
Executive Vice President
dstepanek@cfsg1.com
With more than 20 years of broad experience in investor relations, public relations and media relations, Mr. Stepanek also serves as Managing Partner, KCSA Worldwide. With a wealth of contacts in the print and broadcast media, he has particular expertise in developing and implementing investor relations, marketing and communications programs, strategic counseling, and business and trade media relations. Prior to KCSA, which he joined in 1992, he served as Vice President and General Manager, CMF&Z., Inc., a Young & Rubicam Company; Director of Communications, Combustion Engineering Inc.; and Director of Investor Relations, Borg Warner Corp. He has earned a B.S. in Biology, Marquette University; M.A. in Journalism, University of Iowa, and an M.B.A in Finance, Loyola University of Chicago. He is an avid tennis player and successful marathon runner having completed 10 marathons to date.

Bonnie Barrett Stretch
Executive Vice President
bstretch@cfsg1.com
Ms. Stretch brings extensive experience in strategic corporate communications, positioning companies and clarifying their growth potential to the investor community. Her clients have ranged from financial services companies, telecom associations and emerging technology businesses to healthcare organizations, consumer goods and services, fine arts organizations and publishing. An active member of the International Association of Business Communicators (IABC), she has won numerous awards for editorial excellence and holds a Masters in Journalism from Columbia University.

Adam Brooks
Senior Vice President
abrooks@cfsg1.com
Mr. Brooks comes to CFSG1 with a strong background in management, finance and technology. Prior to joining the Company he served as Vice President, Financial Advisor and Regional Technology Coordinator for Morgan Stanley, New York, where he co-managed a $100 million financial portfolio for non-institutional clients. As Regional Technology Coordinator for the Northeast Division of Morgan Stanley, he trained executives and employees throughout the region in the use of proprietary and non-proprietary software and technology applications. In addition, he was responsible for leading over 1500 sales and marketing employees to increase productivity and revenue. He holds a B.S. in Marketing from the State University of New York at Old Westbury, New York.

Meryl Orshan
Executive Director
info@cfsg1.com
Ms. Orshan has served CFSG1 since 1994 and currently handles operations and support services, marketing materials and brochures, group marketing and seminars and various phases of account management and development. Ms. Orshan received a BA degree from Hofstra University in Administration and Marketing.

Joseph A. Mansi
Advisor
jmansi@cfsg1.com
Mr. Mansi has over 30 years’ experience in the field of public and investor relations. A former journalist and corporate communications executive, Mr Mansi served as a Managing Partner at KCSA Public Relations, where he specialized in investor relations representing both small and large cap corporations. He is an accredited member of the Public Relations Society of America and has lectured widely on investor relations.

Gilbert D. Raker
Advisor
graker@cfsg1.com
With more than 20 years’ experience in business development, Mr. Raker is Chairman, President and CEO of SEMX Corporation, where he successfully led the company from a single-facility, privately-held business to a public corporation with a worldwide presence. Previously, he was a Managing Director and Partner of Ditri Associates, Inc. (DAI), a private investment company, and Executive Vice President of CPC Holdings/Kenmare Capital Corporation, another private investment company, where he negotiated and structured acquisitions, oversaw financial management and controlled the portfolio of several operating businesses.

Robin L. Smith, M.D., M.B.A
Senior Advisor
rsmith@neostem.com
Prior to being appointed Chairman of the Board of Directors and Chief Executive Officer of NeoStem, Inc., (NEOI.OB) an adult stem cell collection processing company, Dr. Smith has acted as a senior advisor and investor to both publicly traded and a long term storage company as well as privately held companies including but not limited to China Biopharmaceutical Holdings, Phase III Medical, the Madelin Fund, HC Innovations inc, Navstar Media Holdings, Strike Force, Red Lion Partners and Health Quest, where she has played a significant role in restructuring and or growing the companies. Additionally, she assists multiple investment banks including Capital Growth Financial, Duncan Capital and Wellfleet Partners where she evaluated companies in healthcare, media and emerging technologies. Dr. Smith also serves on the Board of Trustees of the NYU School of Medicine Foundation (becoming the NYU Medical Center Board) and Co-Chairman of the Board of Directors for the New York University Hospital for Joint Diseases where she is heads up new development efforts and board member recruitment. She was also recently appointed to the Chemotherapy Foundation Board of Trustees, The New York Theatre Ballet and Choose Living.

Prior to these activities, Dr. Smith served as President & Chief Executive Officer of IP2M. During her term, the company was selected as being one of the 10 fastest growing technology companies in Houston. IP2M was sold to a publicly traded company in February of 2003. Before joining the IP2M management team, Dr. Smith was Executive Vice President & Chief Medical Officer for HealthHelp, Inc., a National Radiology Management company which managed 14% of the health care dollars spent by insurance companies such as Aetna, Blue Cross and Blue Shield, and Humana to name a few.

Dr. Smith received her post-graduate training in surgery at the Thomas Jefferson University Hospital and obtained her medical degree from Yale University where she received the Janet M. Glaslow Memorial Achievement Citation, was elected to Alpha Omega Alpha and chosen to be a Farr Scholar. Dr. Smith was one of the first graduates of the U.S. Quality Algorithms Managed Care Fellowship between U.S. Healthcare and Thomas Jefferson Medical College. Dr. Smith's interest in medical management led her to pursue a Masters Degree in business administration at the renowned Wharton School of Business where in sixteen months she completed a double major in health care administration and operations management as well as made the Directors List. As the creator of the bimonthly Managed Care Clinical Corner editorial, Dr. Smith was appointed to the editorial board of Disease Management. Dr. Smith serves on the Houston Technology Advisory Board in addition to the GlaxoSmithKline Advisory Board and holds memberships in National Association of Managed Care Physicians, American College of Physician Executives, American Association for the Advancement of Science, Society for Neuroscience, and the Association for Chemoreception Sciences. Additionally, Dr. Smith was a consultant to the Department of Health Policy and the Clinical Outcomes Department at Thomas Jefferson Hospital and the Utilization Department of Methodist Hospital. Dr. Smith has been published extensively dealing with marketing, computer usage in office settings, clinical practice, management and data mining.